Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in MYGN — Myriad Genetics Inc

CIK 1115418 BOSTON, MA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$687,501
+$158,342 QoQ
Shares Held
120,403
+2.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,233,577,400 across 30 Diagnostics & Research names. MYGN ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 593,946 $297,780,766
2 DHR
Danaher Corp /De/
 995,923 $189,703,413
3 ILMN
Illumina, Inc.
 560,716 $98,590,694
4 IDXX
Idexx Laboratories Inc /De
 169,208 $89,077,859
5 A
Agilent Technologies, Inc.
 500,807 $66,522,193
6 IQV
Iqvia Holdings Inc.
 332,138 $64,175,704
7 WAT
Waters Corp /De/
 168,771 $63,295,875
8 DGX
Quest Diagnostics Inc
 267,727 $56,744,737

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $687,501 120,403
2026-03-31 $529,159 117,591
2025-12-31 $1,696,532 275,859
2025-09-30 $2,097,025 290,045
2025-06-30 $1,619,066 304,909
2025-03-31 $2,470,064 278,474
2024-12-31 $3,969,072 289,502
2024-09-30 $7,596,835 277,358
2024-06-30 $6,932,820 283,435
2024-03-31 $5,898,689 276,674
2023-12-31 $5,191,189 271,222
2023-09-30 $4,319,684 269,307
2023-06-30 $6,212,100 267,994
2023-03-31 $6,248,266 268,974
2022-12-31 $3,739,110 257,692
2022-09-30 $4,705,757 246,633
2022-06-30 $4,317,246 237,603
2022-03-31 $5,721,433 227,041
2021-12-31 $6,288,025 227,827
2021-09-30 $7,435,418 230,270
2021-06-30 $7,846,889 256,602
2021-03-31 $8,060,145 264,701
2020-12-31 $5,235,313 264,811
2020-09-30 $3,076,266 235,910
2020-06-30 $2,846,181 250,986
2020-03-31 $3,803,211 265,773